![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Seegene's Allplex Respiratory Virus Assay Gains CE-IVD Mark
Seegene's Allplex Respiratory Virus Assay Gains CE-IVD Mark
South Korea-based Seegene’s Allplex RV Master assay for respiratory viruses has received a CE-IVD mark.
The test can identify 19 different respiratory viruses, including COVID-19, influenza, respiratory syncytial virus (RSV), adenovirus and human rhinovirus, enabling healthcare professionals to quickly find out from a single sample which viruses are making the patient sick.
The assay can identify three genes of COVID-19, Flu A, Flu B, metapneumovirus, two types of RSV, four types of parainfluenza virus, six types of adenovirus and three types of human rhinovirus.
A recent independent clinical test of the assay in Europe with 1,928 participants found that 16.5 percent (318 people) tested positive for respiratory viruses, excluding COVID-19.
Upcoming Events
-
21Oct